Viewing nowRosuvastatin Tablets 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 201000991 · Approved 2010.01.28 · Insurance code 641804750
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This medication is an adjunct used when dietary management and exercise are insufficient for controlling blood lipid levels in conditions such as primary hypercholesterolemia and combined hyperlipidemia. It is particularly helpful in lowering total cholesterol and LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia and hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also used as a dietary adjunct in pediatric patients aged 10 to 17 with certain conditions. Additionally, it is beneficial for patients with primary dysbetalipoproteinemia. This medication contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization procedures in elderly adults at high risk for cardiovascular disease. Overall, it is used to improve blood lipid levels and reduce the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals allergic to any of the components of this medication, those with severe liver dysfunction, and those with muscle diseases should not take it. Also, those with significantly impaired kidney function or women who are pregnant or breastfeeding may be at risk if they take this medication. In particular, individuals prone to muscle diseases should avoid high doses, and those with genetic issues such as lactose intolerance should also refrain from taking it. Before taking this medication, it is essential to check liver function and muscle condition. Those who consume excessive alcohol or have a history of liver disease should be cautious, and treatment of the underlying cause should be done before administering the medication to individuals with hypothyroidism or nephrotic syndrome. If symptoms such as muscle pain, weakness, or cramps occur during treatment, inform a physician immediately, and the medication may need to be discontinued. In cases of acute illness or severe conditions, discontinuation of this medication should be considered, and immediate cessation is required if severe muscle weakness or ophthalmoplegia occurs. Additionally, caution is needed as the risk of muscle side effects may increase when certain other medications are used concurrently. This medication may cause proteinuria in blood tests, though this is mostly temporary and does not lead to severe renal failure. However, it is advisable to undergo regular kidney function tests during high-dose therapy. The concentration of this medication in the body may be higher in Asians, so dosage adjustments may be necessary. Rarely, side effects such as headaches, dizziness, dyspepsia, skin rashes, myalgia may occur during therapy. If severe skin reactions or liver damage symptoms appear, discontinue use immediately and consult healthcare personnel. The safety of this medication during pregnancy and lactation has not been established, so it should be avoided. Women who could become pregnant should use appropriate contraception. In case of overdose, there is no specific antidote, so treatment should be based on symptoms, along with checking liver function and muscle enzyme levels. Caution is needed as dizziness may occur when driving or operating machinery. Lastly, this medication can interact with several other drugs, so inform your physician or pharmacist if you are on other medications.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is best to keep it at room temperature between 1°C and 30°C, away from extreme heat or cold.
Pink, round film-coated tablet
28 tablets (14 tablets/PTP*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.